FDA approves opioid overdose antidote Zimhi

The FDA has approved Zimhi, a high-dose naloxone product that is administered through a prefilled syringe to counteract potentially fatal opioid overdoses, the agency and the drug’s manufacturer announced. The approval comes amid CDC data that indicate 70.6% of the 70,630 drug overdose deaths in the United States in 2019 involved opioids. According to provisional data from the CDC, more

Read the full article here

Related Articles